| Financial Year |
March 31 2023 |
| Monetary Funds |
1,552,101,183.45 |
| Held-for-trading Financial Assets |
231,596,440.76 |
| Notes Receivable |
44,448,154.80 |
| Accounts Receivable |
1,422,915,080.11 |
| Advances to Suppliers |
3,954,286.84 |
| Other Receivables |
31,495,371.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
655,367,628.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
118,422,624.98 |
| Total Current Assets |
4,213,570,362.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
98,660,279.52 |
| Investment Properties |
-- |
| Fixed Assetes |
158,891,512.20 |
| Under-construction Projects |
374,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,899,418.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
601,561.01 |
| Deferred Income Tax Assets |
205,135,560.04 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
688,599,919.55 |
| Total Assets |
4,902,170,282.53 |
| Short-Term Loans |
27,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
173,863,934.64 |
| Accounts Payable |
740,035,011.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,008,508.70 |
| Taxes Payable |
56,863,231.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
46,865,711.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,300,364.37 |
| Other Current Liabilities |
161,780,738.53 |
| Sub-Total of Current Liabilities |
2,124,553,863.05 |
| Long-term Loans |
-- |
| Bonds Payable |
476,304,841.05 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
49,469,582.54 |
| Deferred Income Tax Liabilities |
9,802,074.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
535,576,498.02 |
| Total Liabilities |
2,660,130,361.07 |
| Paid-In Capital(Or Share Stock) |
596,350,356.00 |
| Capital Surplus |
476,506,492.78 |
| Surplus Reserve |
162,677,097.94 |
| LESS:Treasury Stock |
29,177,183.20 |
| Undistributed Profits |
1,003,215,299.39 |
| Minority Stockholder's Interest |
13,343.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,242,026,578.02 |
| Owner's Equity（Stockholder's Equity） |
2,242,039,921.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,902,170,282.53 |
